Intellipharmaceutics International Inc. (IPCI)

[xr_biotech_consult]

Pursuant to Rule 415(a)(6) under the Securities Act, this Registration Statement includes $86,920,938 of securities that were previously registered, but were not sold, pursuant to the registrant’s registration statement on Form F-3 (File No. 333-196112) (the “Prior Registration Statement”), including $4,095,270 that may be sold under the registrant’s current at-the-market equity offering program and common shares that are issuable upon the exercise of warrants previously issued by the registrant. The Prior Registration Statement registered securities for a maximum aggregate offering price of $100,000,000 and of that amount, the registrant has sold securities for an aggregate offering price of $13,079,062, leaving a balance of unsold securities with an aggregate offering price of $86,920,938.